Global medical technology business Smith & Nephew has appointed a director at AstraZeneca as its new Chief Financial Officer (CFO) to replace Adrian Hennah when he leaves at the end of December.
Julie Brown, who has worked for AstraZeneca for 25 years, will formally takeover the role in early February.
At AstraZeneca she held a number of senior financial and management positions including Regional Vice President of Latin America, Marketing Company President in Portugal, Vice President of Corporate Strategy and Research, and Development Chief Financial Officer. Most recently she held the role of interim CFO.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Olivier Bohuon, Chief Executive Smith & Nephew, said: "Julie is an outstanding leader who brings to Smith & Nephew exceptional financial expertise and a deep knowledge of the healthcare market. Her ability to build teams and her broad experience working across geographies and within senior commercial roles will undoubtedly enable her to be a strong business partner. I look forward to working closely together as we continue to reshape Smith & Nephew for future success."
It was announced in mid-September that Hennah had accepted a job at consumer goods multi-national Reckitt Benckiser.
The share price rose 0.08% to 641p by 13:37.
NR
-
Cash in on the growth prospects of Europe's companiesOpinion Marcel Stötzel, co-portfolio manager of the Fidelity European Trust, selects three stocks
-
Is the AI boom another dotcom bubble?25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
